Crowdonomics
EMULATE THERAPEUTICS, INC.

Reg CF · Common Stock · Oct 2025

ClosedReg CFCommon Equity
via WeFunder · last checked Aug 17, 2026
Raised
$0 / $1.2M max
0% of ceiling
Investors
—
—
Valuation
—
—

Financials disclosed in this offering

FY2023–FY2024 · hover for source
$64K
−$22.9M
FY2023
$0
−$19.1M
FY2024
RevenueNet income
Metric
FY2023 reviewed
FY2024 reviewed
Income statement
Revenue
$64,000
$0
Cost of goods sold
$0
$0
Gross margin
100%
—
Net income
-$22,926,000
-$19,139,000
Taxes paid
$0
$0
Balance sheet
Cash
$240,000
$54,000
Accounts receivable
$300,000
$285,000
Total assets
$2,012,000
$1,193,000
Short-term debt
$28,225,000
$30,988,000
Long-term debt
$5,676,000
$5,655,000
Total liabilities
$33,901,000
$36,643,000
Other
Headcount
—
3

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Price / share$10.54
Shares offered5,932

Offering details

Target$50,000
Max$1,235,000
Min investment—
OpenedOct 8, 2025
DeadlineApr 30, 2026
ClosedApr 30, 2026
Days active204

Links & provenance

Source: SEC EDGAR
0001254348-25-000003
Last synced Aug 17, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.